These novel treatments, Retatrutide, represent a significant advancement in managing metabolic dysfunction and conceivably associated conditions . These drugs are classified as GLP-1 pathway agonists , https://liliancbcc387544.mybjjblog.com/retatrutide-a-deep-exploration-into-incretin-copyright-53700416